Supramolecular nanostructures that mimic VEGF as a strategy for ischemic tissue repair

Matthew J. Webber, Jörn Tongers, Christina J. Newcomb, Katja Theres Marquardt, Johann Bauersachs, Douglas W. Losordo, Samuel I Stupp

Research output: Contribution to journalArticle

179 Citations (Scopus)

Abstract

There is great demand for the development of novel therapies for ischemic cardiovascular disease, a leading cause of morbidity and mortality worldwide. We report here on the development of a completely synthetic cell-free therapy based on peptide amphiphile nanostructures designed to mimic the activity of VEGF, one of the most potent angiogenic signaling proteins. Following selfassembly of peptide amphiphiles, nanoscale filaments form that display on their surfaces a VEGF-mimetic peptide at high density. The VEGF-mimetic filaments were found to induce phosphorylation of VEGF receptors and promote proangiogenic behavior in endothelial cells, indicated by an enhancement in proliferation, survival, and migration in vitro. In a chicken embryo assay, these nanostructures elicited an angiogenic response in the host vasculature. When evaluated in a mouse hind-limb ischemia model, the nanofibers increased tissue perfusion, functional recovery, limb salvage, and treadmill endurance compared to controls, which included the VEGF-mimetic peptide alone. Immunohistological evidence also demonstrated an increase in the density of microcirculation in the ischemic hind limb, suggesting the mechanism of efficacy of this promising potential therapy is linked to the enhanced microcirculatory angiogenesis that results from treatment with these polyvalent VEGF-mimetic nanofibers.

Original languageEnglish
Pages (from-to)13438-13443
Number of pages6
JournalProceedings of the National Academy of Sciences of the United States of America
Volume108
Issue number33
DOIs
Publication statusPublished - Aug 16 2011

Fingerprint

Nanostructures
Vascular Endothelial Growth Factor A
Nanofibers
Peptides
Extremities
Angiogenic Proteins
Artificial Cells
Limb Salvage
Vascular Endothelial Growth Factor Receptor
Microcirculation
Cell- and Tissue-Based Therapy
Chickens
Cardiovascular Diseases
Therapeutics
Ischemia
Embryonic Structures
Endothelial Cells
Perfusion
Phosphorylation
Morbidity

ASJC Scopus subject areas

  • General

Cite this

Supramolecular nanostructures that mimic VEGF as a strategy for ischemic tissue repair. / Webber, Matthew J.; Tongers, Jörn; Newcomb, Christina J.; Marquardt, Katja Theres; Bauersachs, Johann; Losordo, Douglas W.; Stupp, Samuel I.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 108, No. 33, 16.08.2011, p. 13438-13443.

Research output: Contribution to journalArticle

Webber, Matthew J. ; Tongers, Jörn ; Newcomb, Christina J. ; Marquardt, Katja Theres ; Bauersachs, Johann ; Losordo, Douglas W. ; Stupp, Samuel I. / Supramolecular nanostructures that mimic VEGF as a strategy for ischemic tissue repair. In: Proceedings of the National Academy of Sciences of the United States of America. 2011 ; Vol. 108, No. 33. pp. 13438-13443.
@article{0bbed0d01127451fb3805612c64fb26f,
title = "Supramolecular nanostructures that mimic VEGF as a strategy for ischemic tissue repair",
abstract = "There is great demand for the development of novel therapies for ischemic cardiovascular disease, a leading cause of morbidity and mortality worldwide. We report here on the development of a completely synthetic cell-free therapy based on peptide amphiphile nanostructures designed to mimic the activity of VEGF, one of the most potent angiogenic signaling proteins. Following selfassembly of peptide amphiphiles, nanoscale filaments form that display on their surfaces a VEGF-mimetic peptide at high density. The VEGF-mimetic filaments were found to induce phosphorylation of VEGF receptors and promote proangiogenic behavior in endothelial cells, indicated by an enhancement in proliferation, survival, and migration in vitro. In a chicken embryo assay, these nanostructures elicited an angiogenic response in the host vasculature. When evaluated in a mouse hind-limb ischemia model, the nanofibers increased tissue perfusion, functional recovery, limb salvage, and treadmill endurance compared to controls, which included the VEGF-mimetic peptide alone. Immunohistological evidence also demonstrated an increase in the density of microcirculation in the ischemic hind limb, suggesting the mechanism of efficacy of this promising potential therapy is linked to the enhanced microcirculatory angiogenesis that results from treatment with these polyvalent VEGF-mimetic nanofibers.",
author = "Webber, {Matthew J.} and J{\"o}rn Tongers and Newcomb, {Christina J.} and Marquardt, {Katja Theres} and Johann Bauersachs and Losordo, {Douglas W.} and Stupp, {Samuel I}",
year = "2011",
month = "8",
day = "16",
doi = "10.1073/pnas.1016546108",
language = "English",
volume = "108",
pages = "13438--13443",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "33",

}

TY - JOUR

T1 - Supramolecular nanostructures that mimic VEGF as a strategy for ischemic tissue repair

AU - Webber, Matthew J.

AU - Tongers, Jörn

AU - Newcomb, Christina J.

AU - Marquardt, Katja Theres

AU - Bauersachs, Johann

AU - Losordo, Douglas W.

AU - Stupp, Samuel I

PY - 2011/8/16

Y1 - 2011/8/16

N2 - There is great demand for the development of novel therapies for ischemic cardiovascular disease, a leading cause of morbidity and mortality worldwide. We report here on the development of a completely synthetic cell-free therapy based on peptide amphiphile nanostructures designed to mimic the activity of VEGF, one of the most potent angiogenic signaling proteins. Following selfassembly of peptide amphiphiles, nanoscale filaments form that display on their surfaces a VEGF-mimetic peptide at high density. The VEGF-mimetic filaments were found to induce phosphorylation of VEGF receptors and promote proangiogenic behavior in endothelial cells, indicated by an enhancement in proliferation, survival, and migration in vitro. In a chicken embryo assay, these nanostructures elicited an angiogenic response in the host vasculature. When evaluated in a mouse hind-limb ischemia model, the nanofibers increased tissue perfusion, functional recovery, limb salvage, and treadmill endurance compared to controls, which included the VEGF-mimetic peptide alone. Immunohistological evidence also demonstrated an increase in the density of microcirculation in the ischemic hind limb, suggesting the mechanism of efficacy of this promising potential therapy is linked to the enhanced microcirculatory angiogenesis that results from treatment with these polyvalent VEGF-mimetic nanofibers.

AB - There is great demand for the development of novel therapies for ischemic cardiovascular disease, a leading cause of morbidity and mortality worldwide. We report here on the development of a completely synthetic cell-free therapy based on peptide amphiphile nanostructures designed to mimic the activity of VEGF, one of the most potent angiogenic signaling proteins. Following selfassembly of peptide amphiphiles, nanoscale filaments form that display on their surfaces a VEGF-mimetic peptide at high density. The VEGF-mimetic filaments were found to induce phosphorylation of VEGF receptors and promote proangiogenic behavior in endothelial cells, indicated by an enhancement in proliferation, survival, and migration in vitro. In a chicken embryo assay, these nanostructures elicited an angiogenic response in the host vasculature. When evaluated in a mouse hind-limb ischemia model, the nanofibers increased tissue perfusion, functional recovery, limb salvage, and treadmill endurance compared to controls, which included the VEGF-mimetic peptide alone. Immunohistological evidence also demonstrated an increase in the density of microcirculation in the ischemic hind limb, suggesting the mechanism of efficacy of this promising potential therapy is linked to the enhanced microcirculatory angiogenesis that results from treatment with these polyvalent VEGF-mimetic nanofibers.

UR - http://www.scopus.com/inward/record.url?scp=80051967814&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80051967814&partnerID=8YFLogxK

U2 - 10.1073/pnas.1016546108

DO - 10.1073/pnas.1016546108

M3 - Article

VL - 108

SP - 13438

EP - 13443

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 33

ER -